What is the association of COVID-19 with heart attacks and strokes?

por Mafham, Marion, Baigent, Colin
Publicado 2021

Variability in aspirin efficacy: all in the genes?

por Baigent, Colin, Holmes, Michael V
Publicado 2019

The role of lipoprotein (a) in chronic kidney disease

por Hopewell, Jemma C., Haynes, Richard, Baigent, Colin
Publicado 2018

Neprilysin inhibition in chronic kidney disease

por Judge, Parminder, Haynes, Richard, Landray, Martin J., Baigent, Colin
Publicado 2015

The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: a call to action

por Francis, Anna, Baigent, Colin, Ikizler, T. Alp, Cockwell, Paul, Jha, Vivekanand
Publicado 2021

Estimated Glomerular Filtration Rate and the Risk of Major Vascular Events and All-Cause Mortality: A Meta-Analysis

por Mafham, Marion, Emberson, Jonathan, Landray, Martin J., Wen, Chi-Pang, Baigent, Colin
Publicado 2011

Evidence for the Prevention and Treatment of Stroke in Dialysis Patients

por Herrington, William, Haynes, Richard, Staplin, Natalie, Emberson, Jonathan, Baigent, Colin, Landray, Martin
Publicado 2015

Chronic kidney disease, heart failure and neprilysin inhibition

por Haynes, Richard, Zhu, Doreen, Judge, Parminder K, Herrington, William G, Kalra, Philip A, Baigent, Colin
Publicado 2020

Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK Biobank

por Zhu, Pengfei, Lewington, Sarah, Haynes, Richard, Emberson, Jonathan, Landray, Martin J., Cherney, David, Woodward, Mark, Baigent, Colin, Herrington, William G., Staplin, Natalie
Publicado 2020

Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease

por Schlackow, Iryna, Kent, Seamus, Herrington, William, Emberson, Jonathan, Haynes, Richard, Reith, Christina, Collins, Rory, Landray, Martin J., Gray, Alastair, Baigent, Colin, Mihaylova, Borislava
Publicado 2019

Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD

por Morton, Rachael L., Schlackow, Iryna, Staplin, Natalie, Gray, Alastair, Cass, Alan, Haynes, Richard, Emberson, Jonathan, Herrington, William, Landray, Martin J., Baigent, Colin, Mihaylova, Borislava
Publicado 2016

Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials

por Staplin, Natalie, Roddick, Alistair J., Emberson, Jonathan, Reith, Christina, Riding, Alex, Wonnacott, Alexa, Kuverji, Apexa, Bhandari, Sunil, Baigent, Colin, Haynes, Richard, Herrington, William G
Publicado 2021

A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease

por Schlackow, Iryna, Kent, Seamus, Herrington, William, Emberson, Jonathan, Haynes, Richard, Reith, Christina, Wanner, Christoph, Fellström, Bengt, Gray, Alastair, Landray, Martin J, Baigent, Colin, Mihaylova, Borislava
Publicado 2017

Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK

por Zhou, Junwen, Wu, Runguo, Williams, Claire, Emberson, Jonathan, Reith, Christina, Keech, Anthony, Robson, John, Wilkinson, Kenneth, Armitage, Jane, Gray, Alastair, Simes, John, Baigent, Colin, Mihaylova, Borislava
Publicado 2023

Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP)

por Haynes, Richard, Staplin, Natalie, Emberson, Jonathan, G. Herrington, William, Tomson, Charles, Agodoa, Lawrence, Tesar, Vladimir, Levin, Adeera, Lewis, David, Reith, Christina, Baigent, Colin, Landray, Martin J.
Publicado 2014

What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?

por Kent, Seamus, Schlackow, Iryna, Lozano-Kühne, Jingky, Reith, Christina, Emberson, Jonathan, Haynes, Richard, Gray, Alastair, Cass, Alan, Baigent, Colin, Landray, Martin J, Herrington, William, Mihaylova, Borislava
Publicado 2015

Impact of CKD on Household Income

por Morton, Rachael L., Schlackow, Iryna, Gray, Alastair, Emberson, Jonathan, Herrington, William, Staplin, Natalie, Reith, Christina, Howard, Kirsten, Landray, Martin J., Cass, Alan, Baigent, Colin, Mihaylova, Borislava
Publicado 2017

Impact of Outcome Adjudication in Kidney Disease Trials: Observations From the Study of Heart and Renal Protection

por Herrington, William G., Harper, Charlie, Staplin, Natalie, Haynes, Richard, Emberson, Jonathan R., Reith, Christina, Hooi, Lai Seong, Levin, Adeera, Wanner, Christoph, Baigent, Colin, Landray, Martin J.
Publicado 2023

Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) – results of a randomized controlled clinical trial

por Haynes, Richard, Blackwell, Lisa, Staplin, Natalie, Herrington, William G., Emberson, Jonathan, Judge, Parminder K., Storey, Benjamin C., Landray, Martin J., Harden, Paul N., Baigent, Colin, Friend, Peter
Publicado 2018

The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study

por Herrington, William G, Preiss, David, Haynes, Richard, von Eynatten, Maximilian, Staplin, Natalie, Hauske, Sibylle J, George, Jyothis T, Green, Jennifer B, Landray, Martin J, Baigent, Colin, Wanner, Christoph
Publicado 2018